Ascorbix (buffered C recalls
The FDA has published 2 recalls involving Ascorbix (buffered C since 2020. The latest was reported on 11 Mar 2020. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2020
Last 12 months0reported
Class I00% of total
Ongoing0latest 11 Mar 2020
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why ascorbix (buffered c is recalled
Companies
By year
All ascorbix (buffered c recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | AscorbiX (Buffered C) Injection recalled by Fusion IV Pharmaceuticals | Fusion IV Pharmaceuticals | Sterility | Nationwide |
| Drug | CLASS II | AscorbiX (Buffered C) Injection recalled by Fusion IV Pharmaceuticals | Fusion IV Pharmaceuticals | Sterility | Nationwide |
Should you stop taking Ascorbix (buffered C?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.